ATE379990T1 - Verfahren zur darstellung von abgestorbenen zellen in-vivo - Google Patents

Verfahren zur darstellung von abgestorbenen zellen in-vivo

Info

Publication number
ATE379990T1
ATE379990T1 AT98920065T AT98920065T ATE379990T1 AT E379990 T1 ATE379990 T1 AT E379990T1 AT 98920065 T AT98920065 T AT 98920065T AT 98920065 T AT98920065 T AT 98920065T AT E379990 T1 ATE379990 T1 AT E379990T1
Authority
AT
Austria
Prior art keywords
vivo
dead cells
displaying
displaying dead
cells
Prior art date
Application number
AT98920065T
Other languages
English (en)
Inventor
Francis Blankenberg
H Strauss
Jonathan Tait
Peter Katsikis
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Application granted granted Critical
Publication of ATE379990T1 publication Critical patent/ATE379990T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
    • A61B6/03—Computed tomography [CT]
    • A61B6/037—Emission tomography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
    • A61B6/4057—Arrangements for generating radiation specially adapted for radiation diagnosis by using radiation sources located in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/425—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector using detectors specially adapted to be used in the interior of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
    • A61B6/42—Arrangements for detecting radiation specially adapted for radiation diagnosis
    • A61B6/4208—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector
    • A61B6/4258—Arrangements for detecting radiation specially adapted for radiation diagnosis characterised by using a particular type of detector for detecting non x-ray radiation, e.g. gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Radiology & Medical Imaging (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Hydroponics (AREA)
AT98920065T 1997-04-30 1998-04-28 Verfahren zur darstellung von abgestorbenen zellen in-vivo ATE379990T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4539997P 1997-04-30 1997-04-30

Publications (1)

Publication Number Publication Date
ATE379990T1 true ATE379990T1 (de) 2007-12-15

Family

ID=21937648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98920065T ATE379990T1 (de) 1997-04-30 1998-04-28 Verfahren zur darstellung von abgestorbenen zellen in-vivo

Country Status (16)

Country Link
US (3) US6197278B1 (de)
EP (1) EP1017318B1 (de)
JP (1) JP4963748B2 (de)
KR (1) KR20010020443A (de)
CN (1) CN1265572A (de)
AT (1) ATE379990T1 (de)
AU (1) AU754577B2 (de)
CA (1) CA2288131A1 (de)
DE (1) DE69838811T2 (de)
ES (1) ES2398118T3 (de)
HU (1) HUP0001261A3 (de)
NZ (1) NZ500598A (de)
PL (1) PL336571A1 (de)
RU (1) RU2228765C2 (de)
TW (1) TW541184B (de)
WO (1) WO1998048699A1 (de)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2398118T3 (es) * 1997-04-30 2013-03-13 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de formación de imágenes de muerte celular in vivo
US7736651B1 (en) * 2000-11-24 2010-06-15 Sloan-Kettering Institute For Cancer Research Alpha emitting constructs and uses thereof
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
AU771224B2 (en) 1998-07-13 2004-03-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
AU750414B2 (en) 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
US6818213B1 (en) 1998-07-13 2004-11-16 Board Of Regents, The University Of Texas System Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids
US6692724B1 (en) 1999-10-25 2004-02-17 Board Of Regents, The University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
US7067111B1 (en) * 1999-10-25 2006-06-27 Board Of Regents, University Of Texas System Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging
DK1286704T3 (da) 2000-06-02 2014-09-22 Univ Texas Ethylendicystein (EC)-glucose analoge konjugater
AU2001272967A1 (en) * 2000-06-22 2002-01-02 Henry Ford Health System Imaging and targeting tumors using sickle cells
CA2443314C (en) * 2001-04-03 2006-03-21 The Board Of Trustees Of The Leland Stanford Junior University Method of imaging cell death in vivo
US20050013778A1 (en) * 2001-04-03 2005-01-20 Theseus Imaging Corporation Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell death
US6843980B2 (en) 2001-04-03 2005-01-18 Theseus Imaging, Corp. Methods for using annexin for detecting cell death in vivo and treating associated conditions
CA2444483A1 (en) * 2001-04-26 2002-11-07 Board Of Regents, The University Of Texas System Diagnostic imaging compositions, their methods of synthesis and use
US20030202937A1 (en) * 2001-06-05 2003-10-30 Sabbadini Roger A. Minicell-based diagnostics
US20030152513A1 (en) * 2001-09-06 2003-08-14 Imetrix, Inc. Intravascular delivery of therapeutic and imaging agents to stressed and apoptotic cells using annexin V as a targeting vector
US7261875B2 (en) 2001-12-21 2007-08-28 Board Of Regents, The University Of Texas System Dendritic poly (amino acid) carriers and methods of use
US20040042959A1 (en) * 2002-08-28 2004-03-04 Michael Montalto Imaging cell death in vivo using non-radionuclide contrast agents
EP2316493A3 (de) * 2002-11-07 2011-08-10 Board of Regents, The University of Texas System Ethylendicystein(ec)-Aarzneimittelkonjugate, Zusammensetzungen und Verfahren für die gewebsspezifische Darstellung von Krankheiten
US20070031333A1 (en) * 2003-01-02 2007-02-08 Mease Ronnie C Novel F-18 labeled annexin V, synthesis thereof, and use thereof
US9050378B2 (en) * 2003-12-10 2015-06-09 Board Of Regents, The University Of Texas System N2S2 chelate-targeting ligand conjugates
RU2386449C2 (ru) * 2004-01-15 2010-04-20 Эйпосенс Лтд. Соединения, связывающиеся с нарушенной мембраной, и их применение
US7511016B2 (en) * 2004-07-07 2009-03-31 Mosamedix B.V. Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof
WO2006111883A2 (en) * 2005-04-22 2006-10-26 Koninklijke Philips Electronics, N.V. Digital silicon photomultiplier for tof-pet
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
US9623129B2 (en) * 2005-09-26 2017-04-18 Snip Holdings, Inc. Methods and therapies for treating inflammatory conditions with exposed collagen
AU2006306592A1 (en) * 2005-10-21 2007-05-03 Immunochemistry Technologies, Llc In vivo detection of apoptosis
US7871623B2 (en) * 2005-12-21 2011-01-18 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for imaging pain and stress in vivo
US8758723B2 (en) 2006-04-19 2014-06-24 The Board Of Regents Of The University Of Texas System Compositions and methods for cellular imaging and therapy
CN101490581A (zh) * 2006-07-21 2009-07-22 皇家飞利浦电子股份有限公司 用于改进的tof pet重建的方法和系统
US10925977B2 (en) * 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
ES2414614T3 (es) * 2007-01-30 2013-07-22 Ge Healthcare Limited Herramientas para ayudar en el diagnóstico de enfermedades neurodegenerativas
RU2473099C2 (ru) * 2007-05-16 2013-01-20 Конинклейке Филипс Электроникс Н.В. Виртуальный детектор рет и схема квазипикселированного считывания для рет
US8055039B2 (en) * 2008-02-21 2011-11-08 General Electric Company System and method to obtain noise mitigated monochromatic representation for varying energy level
US8916570B2 (en) 2008-03-31 2014-12-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor agonists and antagonists
CA2720037C (en) * 2008-03-31 2016-08-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Purine derivatives as a3 adenosine receptor-selective agonists
CA2732320C (en) * 2008-08-01 2017-08-29 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services A3 adenosine receptor antagonists and partial agonists
US9181253B2 (en) 2008-08-01 2015-11-10 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Adenosine receptor agonists, partial agonists, and antagonists
US8747808B2 (en) 2008-08-26 2014-06-10 Mosamedix B.V. Radiolabeled annexins
US8283167B2 (en) * 2009-02-11 2012-10-09 Clear Vascular Inc. Preparation of annexin derivatives
CN103582504B (zh) 2011-04-04 2016-04-27 艾迪国际研发有限公司 用于无针注射器的安全注射筒
RU2015155001A (ru) * 2013-05-23 2017-06-28 НьюроСн, Инк. Диагностика и лечение болезни альцгеймера с использованием аннексинов, меченных радионуклидом
CN105669855B (zh) * 2016-02-04 2020-02-11 江苏省原子医学研究所 一种18F快速标记Cys-Annexin V的方法及其应用
RU2622983C1 (ru) * 2016-07-25 2017-06-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ интраоперационной визуализации ишемически-реперфузионного повреждения миокарда
WO2019169241A1 (en) * 2018-03-02 2019-09-06 Serene, Llc Methods of treating and imaging ungulate laminitis
JP2024022034A (ja) * 2022-08-05 2024-02-16 浜松ホトニクス株式会社 プログラムされた細胞死を起こした細胞の領域を決定する方法、決定部を備える装置及び決定ステップを含む情報処理プログラム

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4671256A (en) * 1984-05-25 1987-06-09 Lemelson Jerome H Medical scanning, monitoring and treatment system and method
US5627036A (en) 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5552525A (en) 1991-02-08 1996-09-03 Diatech Inc. Technetium-99m labeled peptides for imaging inflammation
EP0538459A4 (en) 1991-05-09 1993-06-16 The Board Of Regents Of The University Of Washington Phospholipid-targeted thrombolytic agents
US5632986A (en) * 1991-05-09 1997-05-27 The University Of Washington Phospholipid-targeted thrombolytic agents
US5519221A (en) 1992-01-22 1996-05-21 Ansel M. Schwartz Dedicated apparatus and method for emission mammography
WO1993017715A1 (en) 1992-03-05 1993-09-16 Board Of Regents, The University Of Texas System Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
US5776427A (en) 1992-03-05 1998-07-07 Board Of Regents, The University Of Texas System Methods for targeting the vasculature of solid tumors
US5965132A (en) 1992-03-05 1999-10-12 Board Of Regents, The University Of Texas System Methods and compositions for targeting the vasculature of solid tumors
GB9223168D0 (en) 1992-11-05 1992-12-16 Johnson Matthey Plc Improvements in molecule labelling
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
US5834196A (en) 1994-04-11 1998-11-10 Nexins Research B.V. Method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
WO1995034315A1 (en) 1994-06-16 1995-12-21 Neorx Corporation Radiolabeled annexin-galactose conjugates
CA2206274C (en) 1994-12-07 2009-06-30 Neorx Corporation Radiolabeled annexin-galactose cluster conjugates
ES2398118T3 (es) * 1997-04-30 2013-03-13 The Board Of Trustees Of The Leland Stanford Junior University Procedimiento de formación de imágenes de muerte celular in vivo
AU771224B2 (en) 1998-07-13 2004-03-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
AU750414B2 (en) 1998-07-13 2002-07-18 Board Of Regents, The University Of Texas System Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids
US6406693B1 (en) 1998-07-13 2002-06-18 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids

Also Published As

Publication number Publication date
PL336571A1 (en) 2000-07-03
DE69838811T2 (de) 2008-10-30
US7357915B2 (en) 2008-04-15
RU2228765C2 (ru) 2004-05-20
US20080138279A1 (en) 2008-06-12
AU7271498A (en) 1998-11-24
KR20010020443A (ko) 2001-03-15
TW541184B (en) 2003-07-11
CN1265572A (zh) 2000-09-06
EP1017318A4 (de) 2003-04-23
CA2288131A1 (en) 1998-11-05
JP2002500757A (ja) 2002-01-08
DE69838811D1 (de) 2008-01-17
NZ500598A (en) 2001-09-28
EP1017318A1 (de) 2000-07-12
JP4963748B2 (ja) 2012-06-27
HUP0001261A2 (hu) 2000-08-28
US7666389B2 (en) 2010-02-23
ES2398118T3 (es) 2013-03-13
US20070243133A1 (en) 2007-10-18
WO1998048699A1 (en) 1998-11-05
US6197278B1 (en) 2001-03-06
EP1017318B1 (de) 2007-12-05
HUP0001261A3 (en) 2001-11-28
AU754577B2 (en) 2002-11-21

Similar Documents

Publication Publication Date Title
DE69838811D1 (de) Verfahren zur darstellung von abgestorbenen zellen in-vivo
ID20500A (id) Metoda untuk memperoleh asam akrilat
IT1303790B1 (it) "apparecchiatura impiantabile di rilevazione elettromiograficainterno-esterno, in particolare per lo studio in vivo dell'attivita'
DE69926639D1 (de) Knochenmarkszellen als quelle von neuronen zur wiederherstellung von gehirn und knochenmark
EP1124598A4 (de) System zur diagnose von harninkontinenz
DE59804782D1 (de) Gitter für die Fixierung von Knochenteilen oder für die Überbrückung von Knochenfehlstellen
DE69903898D1 (de) Teststreifen zur visuellen Ermittlung der Blutglukose-Konzentration
DE69941563D1 (de) Elektrochemisches System zur Bestimmung der Blutgerinnungszeit
ID18631A (id) Proses pembuatan asam l-amino melalui fermentasi
ID21140A (id) Metode produksi asam akrilat
ID27390A (id) Pembuatan asam akrilat
DE69922576D1 (de) Applikator für Knochenmehltransplantate
ID30181A (id) Asam antranilat- dan asam tioantranilat-n-aril amida
DE60117664D1 (de) System zur Befestigung von Weichgewebe an Knochen
DE69924968D1 (de) Verfahren zur differenzierung roter nukleierter blutzellen
DE69721021D1 (de) Blasenmukosa mit zellen für die rekonstruktion von geweben
DE69630955D1 (de) Immortalisierung bzw. desimmortalisierung von zellen
EP1073446A4 (de) Zusammensetzung zur hautbleichung
DE69839016D1 (de) Bilderzeugung mittels ultraschall zur anzeige von gewebespannungen
DE59911626D1 (de) Verfahren zur zweidimensionalen Abbildung von Strukturen für die medizinische Diagnostik
DE69932142D1 (de) Verfahren zur herstellung von nickelpulver
DE60225903D1 (de) In-vivo verfahren zur messung von auf der haut oder dessen komponenten bindenden aktiven chemischen substanzen
ATE279502T1 (de) Verfahren zur gewebepflege
ID17416A (id) Pembuatan asam akrilat
ATE222122T1 (de) Verfahren zur tötung von zielzellen in geernteten zellpopulationen mit hilfe von zwei immunotoxinen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties